Cancer medicine shortages for children around the world

INTEGRATE study: Treatment pathways, outcomes and resource use in patients with multiple myeloma

Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic

Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first-line treatment of CLL in elderly or unfit patients

Lenalidomide and rituximab as front-line chemo-free therapy for elderly frail patients with diffuse large B-cell lymphoma.

Antibody and T-cell responses to COVID-19 vaccination in myeloproliferative neoplasm patients

Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in pts with relapsed/refractory B-cell malignancies

Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma

Latest in advanced endometrial cancer

Oncology nursing in the global south during COVID-19

OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021

Post-HSCT management of ALL - Adult ALL perspective